Cancer clinical trials in the region Île-de-France
261 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Pancreas cancer
#NCT05512377
Adenocarcinoma
Locally Advanced
Metastatic
MDM2
TP53
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Hôpital Beaujon (Clichy), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Boehringer Ingelheim
Phase 2
Lung cancer
#NCT05512377
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Other mutation
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Hôpital Beaujon (Clichy), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Boehringer Ingelheim
Phase 2
Lung cancer
#NCT05882734
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
EGFR
ALK
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier) (and 2 more...)
Merck KGaA
Phase 2
Lymphoma
#NCT04509700
B cell lymphoma
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Incyte Corporation
Phase 2
Colon cancer
Rectal cancer
#NCT04420884
Adenocarcinoma
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Léon Bérard (Lyon), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre François Baclesse (Caen ), Hôpital de la Timone AP-HM (Marseille) (and 7 more...)
Takeda
Phase 2
Breast cancer
#NCT06508216
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Chemotherapy
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Mantel cell lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Follicular lymphoma
CD20
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lymphoma
#NCT03328078
B cell lymphoma
Primary cerebral lymphoma
1
2
3 or more
Systemic Treatment-Naive
Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Hôpital de la Timone AP-HM (Marseille), Hôpital Pitié Salpêtrière - AP-HP (Paris)
Curis, Inc.
Phase 2
Breast cancer
#NCT06298084
HER2 Positive
Locally Advanced
Metastatic
Chemotherapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Gustave Roussy, Campus du cancer, Grand Paris